Jake Bauer has an estimated net worth of $10.3 Million. This is based on reported shares across multiple companies, which include ARYA Sciences Acquisition Corp V, ARYA Sciences Acquisition Corp II, MyoKardia, Inc., Enliven Therapeutics, Inc., Immunovant, Inc., and BridgeBio Oncology Therapeutics, Inc..

2018 was Jake Bauer's most active year for acquiring shares with 10 total transactions. Jake Bauer's most active month to acquire stocks was the month of January. 2018 was Jake Bauer's most active year for disposing of shares, totalling 19 transactions. Jake Bauer's most active month to dispose stocks was the month of December. 2019 saw Jake Bauer paying a total of $423,931.26 for 116,300 shares, this is the most they've acquired in one year. In 2019 Jake Bauer cashed out on 99,043 shares for a total of $3,920,381.70, their largest year based on trade value.